Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Report paints dismal picture of California’s jobs market
Report: U.S. added $1.2 trillion to national debt in six months
Illinois House pushes through bill restricting ICE detention centers in state
Cheaper gas could take time amid tentative ceasefire
Trump says military remains in place as talks with Iran set to begin
Illinois Quick Hits: Ex-nonprofit exec sentenced for state, federal grant fraud
Will County Prepares for Route 66 Centennial with $3.4 Million in Grant Projects
Lawmaker calls for department reform supporting Illinois families with disabled children
Lawyers’ ‘misleading statements’ hang cloud over college finaid class action
Ceasefire impact holds across markets despite varying reports on the Strait of Hormuz
SEC chairman returns ”first principles’ to public markets, supports Texas exchange
Complaint filed against AMA Foundation for racially discriminatory scholarships